Overview

Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

Status:
Unknown status

Trial end date:
2019-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to compare the efficacy of early intervention of PDT combination compared with consecutive monthly treatment of intravitreal ranibizumab injections in PCV patients showing insufficient response with initial loading dose.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Hospital

Collaborator:

Novartis

Treatments:

Ranibizumab